Steroids Found to Limit Effectiveness of Lung Cancer Immunotherapy Treatment - Top-Institutions - MDSpire

Steroids Found to Limit Effectiveness of Lung Cancer Immunotherapy Treatment

Keck Medicine of USC researchers discovered that tumors shrank less in patients who were given steroids for symptoms of lung cancer.

  • By

  • March 8, 2026

  • 7 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Keck Medicine of USC
    Keck Medicine of USC

    Los Angeles, CA

    Key Differentiators

    • Medical Oncology
    • Immunotherapy
    • Thoracic Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Medical Oncology
    • Immunotherapy
    • Thoracic Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Immunotherapy
    • Thoracic Oncology

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Immunotherapy
    • Thoracic Oncology

  • #5

    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

    Baltimore, MD

    Key Differentiators

    • Medical Oncology
    • Immunotherapy
    • Thoracic Oncology

Original Source(s)

Steroids Found to Limit Effectiveness of Lung Cancer Immunotherapy Treatment

  • by

  • March 8, 2026

Related Content

Papillary thyroid carcinoma with brain and lung metastases: a case report

An LDH-based prognostic model for extensive-stage small-cell lung cancer patients treated with chemo-immunotherapy and consolidative thoracic radiotherapy

Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases